Concerning NB, the detection of specific genetic alterations including MYCN and ALK copy number status and clinically actionable ALK mutations including ALK-F1174L and ALK-R1275Q has been extensively reported [37,38,39,40,41,42]. The gene discussed is ALK; the disease is neuroblastoma.